Correlation Between BriaCell Therapeutics and AIM ImmunoTech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BriaCell Therapeutics and AIM ImmunoTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BriaCell Therapeutics and AIM ImmunoTech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BriaCell Therapeutics Corp and AIM ImmunoTech, you can compare the effects of market volatilities on BriaCell Therapeutics and AIM ImmunoTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BriaCell Therapeutics with a short position of AIM ImmunoTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of BriaCell Therapeutics and AIM ImmunoTech.

Diversification Opportunities for BriaCell Therapeutics and AIM ImmunoTech

-0.35
  Correlation Coefficient

Very good diversification

The 3 months correlation between BriaCell and AIM is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding BriaCell Therapeutics Corp and AIM ImmunoTech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AIM ImmunoTech and BriaCell Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BriaCell Therapeutics Corp are associated (or correlated) with AIM ImmunoTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AIM ImmunoTech has no effect on the direction of BriaCell Therapeutics i.e., BriaCell Therapeutics and AIM ImmunoTech go up and down completely randomly.

Pair Corralation between BriaCell Therapeutics and AIM ImmunoTech

Assuming the 90 days horizon BriaCell Therapeutics is expected to generate 2.49 times less return on investment than AIM ImmunoTech. In addition to that, BriaCell Therapeutics is 1.49 times more volatile than AIM ImmunoTech. It trades about 0.0 of its total potential returns per unit of risk. AIM ImmunoTech is currently generating about 0.01 per unit of volatility. If you would invest  38.00  in AIM ImmunoTech on September 3, 2024 and sell it today you would lose (16.00) from holding AIM ImmunoTech or give up 42.11% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.19%
ValuesDaily Returns

BriaCell Therapeutics Corp  vs.  AIM ImmunoTech

 Performance 
       Timeline  
BriaCell Therapeutics 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in BriaCell Therapeutics Corp are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, BriaCell Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
AIM ImmunoTech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AIM ImmunoTech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

BriaCell Therapeutics and AIM ImmunoTech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BriaCell Therapeutics and AIM ImmunoTech

The main advantage of trading using opposite BriaCell Therapeutics and AIM ImmunoTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BriaCell Therapeutics position performs unexpectedly, AIM ImmunoTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AIM ImmunoTech will offset losses from the drop in AIM ImmunoTech's long position.
The idea behind BriaCell Therapeutics Corp and AIM ImmunoTech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance